Diaphragmatic Hiatal Hernia

Diaphragmatic hiatal hernia is a condition where the fundus or gastro-oesophageal junction of the stomach herniates upwards in the chest due to an abnormal defect in the diaphragm. A chest X-ray may reveal gastric air and fluid behind the mediastinum, and reduced air entry at the lung bases due to compression of the lung lobes. Immediate management involves stabilizing the patient with ABCDE and seeking an urgent surgical review for a possible Nissen fundoplication.

Other conditions such as early cholangitis, aspiration pneumonia of the left lower lobe of the lung, ruptured left ventricle, or ruptured right ventricle may present with different symptoms and would not cause the air and fluid level behind the mediastinum seen in diaphragmatic hiatal hernia.

Differential Diagnosis for Acute Hepatitis with Jaundice

Acute hepatitis with jaundice can have various causes, and a differential diagnosis is necessary to determine the underlying condition. In this case, the blood tests indicate significant hepatocellular damage as the cause of the patient’s jaundice, making viral hepatitis the most likely option.

Acute hepatitis B is a common cause of jaundice, especially in endemic regions like Asia. The patient may have acquired the infection through sexual contact or needle-sharing. The acute infection usually lasts for 1-3 months, and most patients make a full recovery.

Acute hepatitis C is less likely as it is usually asymptomatic in adults, and only a small percentage develops symptoms. Primary biliary cholangitis, on the other hand, presents with an insidious onset of pruritus and lethargy, followed by jaundice, and causes a cholestatic picture. Acute alcoholic hepatitis rarely causes an ALT >500 and should be suspected if another cause or concomitant cause is present. Non-alcoholic steatohepatitis (NASH) is chronic and usually leads to mildly abnormal liver function tests in patients with risk factors for the metabolic syndrome.

In conclusion, a thorough differential diagnosis is necessary to determine the underlying cause of acute hepatitis with jaundice, and in this case, viral hepatitis is the most likely option.

Diagnostic Biopsy Findings for Various Intestinal Conditions

When conducting a biopsy of the small intestine, various changes may be observed that can indicate the presence of certain conditions. However, it is important to note that these changes are not always specific to a particular disease and may be found in other conditions as well. Therefore, additional diagnostic tests may be necessary to confirm a diagnosis.

Coeliac disease is one condition that can be suggested by biopsy findings, which may include infiltration by lymphocytes and plasma cells, villous atrophy, and crypt hyperplasia. However, positive serology for anti-endomysial or anti-gliadin antibodies is also needed to confirm gluten sensitivity.

Abetalipoproteinemia, Mycobacterium avium infection, Whipple’s disease, and intestinal lymphangiectasia are other conditions that can be diagnosed based on biopsy findings alone. Abetalipoproteinemia is characterized by clear enterocytes due to lipid accumulation, while Mycobacterium avium infection is identified by the presence of foamy macrophages containing acid-fast bacilli. In Whipple’s disease, macrophages are swollen and contain PAS-positive granules due to the glycogen content of bacterial cell walls. Finally, primary intestinal lymphangiectasia is diagnosed by the dilation of lymphatics in the intestinal mucosa without any evidence of inflammation.

When it comes to distinguishing between ulcerative colitis and Crohn’s disease, one key factor is the presence of crypt abscesses. These are typically seen in ulcerative colitis, which is the more common of the two inflammatory bowel diseases. In ulcerative colitis, inflammation starts in the rectum and spreads continuously up the colon, whereas Crohn’s disease often presents with skip lesions. Patients with ulcerative colitis may experience left-sided abdominal pain, cramping, bloody diarrhea with mucous, and unintentional weight loss. Colonoscopy typically reveals diffuse and contiguous ulceration and inflammatory infiltrates affecting the mucosa and submucosa only, with the presence of crypt abscesses being a hallmark feature. In contrast, Crohn’s disease is characterized by a transmural inflammatory phenotype, with non-caseating granulomas and stricturing of the bowel wall being common complications. Patients with Crohn’s disease may present with right-sided abdominal pain, watery diarrhea, and weight loss, and may have a more systemic inflammatory response than those with ulcerative colitis. Barium enema and colonoscopy can help to differentiate between the two conditions, with the presence of multiple linear ulcers in the bowel wall (rose-thorn appearance) and bowel wall thickening being suggestive of Crohn’s disease.

Distal Intestinal Obstruction Syndrome in Cystic Fibrosis Patients

Distal intestinal obstruction syndrome is a common complication in 10-20% of cystic fibrosis patients, with a higher incidence in adults. The condition is caused by the loss of CFTR function in the intestine, leading to the accumulation of mucous and fecal material in the terminal ileum, caecum, and ascending colon. Diagnosis is made through a plain abdominal radiograph, which shows faecal loading in the right iliac fossa, dilation of the ileum, and an empty distal colon. Ultrasound and CT scans can also be used to identify an obstruction mass and show dilated small bowel and proximal colon.

Treatment for mild and moderate episodes involves hydration, dietetic review, and regular laxatives. N-acetylcysteine can be used to loosen and soften the plugs, while severe episodes may require gastrografin or Klean-Prep. If there are signs of peritoneal irritation or complete bowel obstruction, surgical review should be obtained. Surgeons will often treat initially with intravenous fluids and a NG tube while keeping the patient nil by mouth. N-acetylcysteine can be put down the NG tube.

Overall, distal intestinal obstruction syndrome is a serious complication in cystic fibrosis patients that requires prompt diagnosis and treatment. With proper management, patients can avoid severe complications and maintain their quality of life.

Possible GI Malignancy in a Man with Weight Loss and Microcytic Anaemia

This man is experiencing weight loss and has an unexplained microcytic anaemia. The most probable cause of his blood loss is from the gastrointestinal (GI) tract, as there is no other apparent explanation. This could be due to an occult GI malignancy, which is why the recommended initial investigations are upper and lower GI endoscopy. These tests will help to identify any potential sources of bleeding in the GI tract and determine if there is an underlying malignancy. It is important to diagnose and treat any potential malignancy as early as possible to improve the patient’s prognosis. Therefore, prompt investigation and management are crucial in this case.

The Parts of the Duodenum: A Brief Overview

The duodenum is the first part of the small intestine and is divided into four parts. Each part has its own unique characteristics and functions.

Superior (first part) duodenum: This is the first part of the duodenum that connects the stomach to the small intestine.

Descending (second part) duodenum: The ampulla of Vater, where the common bile duct and pancreatic duct enter the duodenum, is located in this part. It is cannulated during ERCP to access the biliary tree.

Inferior (third part) duodenum: The ampulla of Vater does not join this part, but rather the second part.

Ascending (fourth part) duodenum: This is the last part of the duodenum that joins the jejunum, the second part of the small intestine.

Understanding the different parts of the duodenum is important for diagnosing and treating gastrointestinal disorders.

The patient’s symptoms and lab results suggest that they have acute pancreatitis, which is commonly seen in individuals with alcoholism or gallstone disease. This condition is characterized by severe epigastric pain that may radiate to the back, and an increase in pancreatic enzymes like amylase within 6-12 hours of onset. Lipase levels can also aid in diagnosis, as they rise earlier and last longer than amylase levels. Acute mesenteric ischemia, perforated peptic ulcer, pyelonephritis, and small bowel obstruction are less likely diagnoses based on the patient’s symptoms and medical history.

The patient is suspected to have acute cholecystitis, and a confirmation of the diagnosis will rely on an ultrasound scan of the abdomen. To manage the patient’s symptoms and prevent sepsis, it is essential to administer intravenous antibiotics and fluids. Antiemetics may also be necessary to prevent dehydration from vomiting. It is recommended to keep the patient ‘nil by mouth’ until the scan is performed and consider prescribing analgesia for pain relief. An NG tube is not necessary at this stage, and an OGD or ERCP may be appropriate depending on the scan results. The NICE guidelines recommend cholecystectomy within a week of diagnosis.

Treatment Options for Hepatitis C: Direct Acting Antivirals and Combination Therapies

Hepatitis C is a viral infection that can lead to serious long-term health complications such as cirrhosis and liver cancer. Interferon-based treatments are no longer recommended as first-line therapy for hepatitis C, as direct acting antivirals (DAAs) have proven to be more effective. DAAs target different stages of the hepatitis C virus lifecycle and have a success rate of over 90%. Treatment typically involves a once-daily oral tablet regimen for 8-12 weeks and is most effective when given before cirrhosis develops.

While ribavirin alone is not as effective, combination therapies such as PEG-interferon α and ribavirin have been used in the past. However, for patients with genotype 1 disease (which has a worse prognosis), the addition of a protease inhibitor to the treatment regimen is recommended for better outcomes.

It is important to note that blood-borne infection rates for hepatitis C are high and can occur after just one or two instances of sharing needles during recreational drug use. Testing for hepatitis C involves antibody testing, followed by RNA and genotyping to guide the appropriate combination and length of treatment.

Overall, the combination of PEG-interferon, ribavirin, and a protease inhibitor is no longer used in the treatment of hepatitis C, as newer and more effective therapies have been developed.